about
Ketogenic diet improves core symptoms of autism in BTBR mice.GWAS and transcriptional analysis prioritize ITPR1 and CNTN4 for a serum uric acid 3p26 QTL in Mexican AmericansKetogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder.Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.Adenosine receptors and epilepsy: current evidence and future potential.Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia.Purinergic Signalling: Therapeutic Developments.Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases.Purinergic system in psychiatric diseases.Analysis of Extracellular Nucleotide Metabolism in Adult Zebrafish After Embryological Exposure to Valproic Acid.
P2860
Q34766019-88DFF718-74D7-4CD5-990A-872F169E0775Q35978126-EFF54EF6-53CE-481D-9D35-8E3CD68C1591Q36271744-51D27790-DE21-4D22-A7CA-309505B2335CQ37653680-611EC5F9-83CD-481C-BC38-70160662A73FQ38245140-401E7EE2-46C5-4085-9035-BD7AC59E61BCQ38743021-63F8CBD9-2F07-4088-9E56-95D6C44273EBQ42367885-F68B1BD1-BBED-429F-B9B8-6AA29F07690BQ47551317-7D9B4425-3AF2-4F07-B35E-12A8F9C814D2Q47758170-4578993D-1EB3-4ACE-A178-3DE56007B687Q48729359-62568110-A3A9-403A-9463-C0F893D5950E
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Adenosine and autism: a spectrum of opportunities.
@ast
Adenosine and autism: a spectrum of opportunities.
@en
type
label
Adenosine and autism: a spectrum of opportunities.
@ast
Adenosine and autism: a spectrum of opportunities.
@en
prefLabel
Adenosine and autism: a spectrum of opportunities.
@ast
Adenosine and autism: a spectrum of opportunities.
@en
P2093
P2860
P1433
P1476
Adenosine and autism: a spectrum of opportunities.
@en
P2093
David N Ruskin
Jessica L Cote
Masahito Kawamura
Rebecca B Williams
Susan A Masino
P2860
P304
P356
10.1016/J.NEUROPHARM.2012.08.013
P577
2012-08-24T00:00:00Z